A significant portion of AAL’s structured finance advisory work involves instrument-backed transactions where the instrument itself — and the claims made about it — must be independently assessed before any commitment is made. AAL advises on the following instrument types and associated transaction structures:
Standby Letters of Credit (SBLC)
Assessment of issuance logic, verifiability, proposed monetisation structures, sequencing discipline and counterparty risk. AAL reviews the commercial and procedural integrity of SBLC-backed proposals before a client accepts any issuance, delivery, verification or monetisation sequence.
Bank Guarantees (BG)
Structuring, SWIFT message sequencing (MT799 pre-advice, MT760 issuance), issuing bank assessment and procedural compliance. AAL identifies sequencing errors and documentation gaps before they become transaction failures.
Medium-Term Notes (MTN)
Transaction-structure and ownership-claim assessment, programme-document review and fraud screening. AAL evaluates whether the stated issuer, holder, custody position, settlement route and proposed mechanics can withstand verification.
Deeds of Agreement (DOA)
Commercial review of DOA terms, MT103 payment sequencing, procedure compliance and counterparty obligation logic. AAL reviews DOAs for internal consistency and alignment with stated transaction objectives.
Red flag advisory: AAL has direct experience in structured finance contexts where instrument fraud is the material risk — including fabricated SWIFT messages, misrepresented issuing banks, advance fee payment demands disguised as procedural requirements, and instruments that cannot withstand even basic verification. In the past twelve months alone, files reviewed by AAL have included fabricated SWIFT confirmations attributed to two global banks, an MTN programme whose claimed owner did not exist, and a standby letter of credit whose issuing officer had left the named bank three years earlier. None survived first-pass verification. Where a proposed transaction involves instrument claims that have not been independently verified, counterparties without traceable institutional relationships, or payment requests ahead of instrument delivery, scope a due diligence review before proceeding.
Scope boundary: AAL provides strategic, commercial and due-diligence advisory only. AAL does not act as a broker-dealer, placement agent, lender, asset manager or regulated investment adviser; does not arrange instrument monetisation or capital raising; and does not buy, sell, place, custody or execute transactions in financial instruments.
Counterparty Due Diligence →